Angiopoietin-Like Proteins 4 (ANGPTL4) Gene Polymorphisms and Risk of Brain Arteriovenous Malformation
Overview
Neurology
Authors
Affiliations
Background: Brain arteriovenous malformations (BAVMs) are formed by hypertrophied arterial vessels (afferents, feeders), a large number of arteriovenous shunts which become tangled to form a body (nidus) of malformation, which then expands draining proximal veins. The aim of this study was a replication of single nucleotide polymorphism (SNP) rs11672433 association with BAVM development with the subsequent meta-analysis of published data.
Methods: A total of 252 Russian patients with brain BAVMs and 480 control subjects were included in the present study. Genotyping was performed using real-time polymerase chain reaction with competitive hydrolysis probes.
Results: In our case-control study, we found no significant association with brain arteriovenous malformation for the SNP rs11672433 of ANGPTL4 gene (odds ratio .82, 95% confidence interval = .57-1.17 P value = .27) as well as in meta-analysis (odds ratio 1.18, 95% confidence interval = .81-1.73, P value = .39).
Conclusions: Our data showed that SNP rs11672433 was not associated with the BAVM Russian population and the following meta-analysis did not detect an association in total. Thus, in spite of the fact that ANGPTL4 (protein) participates in the angiogenesis regulation processes, we consider that SNP rs11672433, a high-frequency locus in the ANGPTL4 gene, does not influence the predisposition to BAVM or its effect is too small to be detected in the present size sample set.
LIF-STAT signaling in decidual cells: a possible role in embryo implantation and early pregnancy.
Wu H, Chen L, Chiu W, Tsai C J Mol Endocrinol. 2024; 73(2).
PMID: 38722222 PMC: 11227039. DOI: 10.1530/JME-24-0006.
Association Between the rs1834306 A>G Polymorphism and Susceptibility to Venous Malformation.
Wu G, Lin X, Jiang H, Liu Z Int J Gen Med. 2024; 17:509-515.
PMID: 38356685 PMC: 10864769. DOI: 10.2147/IJGM.S441542.
Wu H, Lo T, Tsai C, Chen L, Huang H, Wang H Pharmaceutics. 2022; 14(6).
PMID: 35745744 PMC: 9230557. DOI: 10.3390/pharmaceutics14061172.